Skip to Main Content

Author Details

Vineet D Menachery
University of Texas Medical Branch
2008
127
52
PMIDPaper TitleJournal TitlePublished Year
36722972SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3.J Virol2023
37634741Coronavirus 2'-O-methyltransferase: A promising therapeutic target.Virus Res2023
37693415SARS-CoV-2 hijacks fragile X mental retardation proteins for efficient infection.bioRxiv2023
37425880Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication.bioRxiv2023
37022178SARS-CoV-2 Inhibits NRF2-Mediated Antioxidant Responses in Airway Epithelial Cells and in the Lung of a Murine Model of Infection.Microbiol Spectr2023
37131784Loss-of-function mutation in Omicron variants reduces spike protein expression and attenuates SARS-CoV-2 infection.bioRxiv2023
37292863The impact of RSV/SARS-CoV-2 co-infection on clinical disease and viral replication: insights from a BALB/c mouse model.bioRxiv2023
34818667The N501Y spike substitution enhances SARS-CoV-2 infection and transmission.Nature2022
35550680Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant.Cell Rep2022
35728038Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis.PLoS Pathog2022
35420471Erratum for Vanderheiden et al., "CCR2 Signaling Restricts SARS-CoV-2 Infection".mBio2022
36146877Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients.Viruses2022
36138032Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth.Nat Commun2022
36203546SARS-CoV-2 Uses Nonstructural Protein 16 to Evade Restriction by IFIT1 and IFIT3.bioRxiv2022
35896528A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.Nat Commun2022
36229471Publisher Correction: A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.Nat Commun2022
35881779QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis.Proc Natl Acad Sci U S A2022
35132410Engineering SARS-CoV-2 cocktail antibodies into a bispecific format improves neutralizing potency and breadth.bioRxiv2022
34933006Analytical characterization of the SARS-CoV-2 EURM-017 reference material.Clin Biochem2022
34671771Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis.bioRxiv2022
32935872SARS-CoV-2 neutralization and serology testing of COVID-19 convalescent plasma from donors with nonsevere disease.Transfusion2021
33494095Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.Nature2021
33514944Engineering SARS-CoV-2 using a reverse genetic system.Nat Protoc2021
33789086The variant gambit: COVID-19's next move.Cell Host Microbe2021
33513210Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice.PLoS Pathog2021
33758846Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants.bioRxiv2021
33758836The N501Y spike substitution enhances SARS-CoV-2 transmission.bioRxiv2021
33564782Infection and mRNA-1273 vaccine antibodies neutralize SARS-CoV-2 UK variant.medRxiv2021
33507952Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium.PLoS Pathog2021
33558724Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera.Nat Med2021
33532771Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K, and N501Y variants by BNT162b2 vaccine-elicited sera.bioRxiv2021
33691138A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence.Cell2021
33501436A <i>trans</i> -complementation system for SARS-CoV-2.bioRxiv2021
33631118A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs.Immunity2021
34941409A new tool to probe SARS-CoV-2 variants.Science2021
34735434Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge.PLoS Biol2021
34581669Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants.Elife2021
34462752Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant.bioRxiv2021
34460863Binding and entering: COVID finds a new home.PLoS Pathog2021
34131306Author Correction: Spike mutation D614G alters SARS-CoV-2 fitness.Nature2021
34043740TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2.PLoS Pathog2021
34158492Author Correction: A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation.Nat Commun2021
34155200Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.Nat Commun2021
34013261Common Mechanism of SARS-CoV and SARS-CoV-2 Pathogenesis across Species.bioRxiv2021
34210985Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape.Nat Commun2021
34342578Endomembrane targeting of human OAS1 p46 augments antiviral activity.Elife2021
34059436Catch Me if You Can: Superspreading of COVID-19.Trends Microbiol2021
34117252SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung.Nat Commun2021
33952616Evaluation of Cellular and Serological Responses to Acute SARS-CoV-2 Infection Demonstrates the Functional Importance of the Receptor-Binding Domain.J Immunol2021
34051754Hypergraph models of biological networks to identify genes critical to pathogenic viral response.BMC Bioinformatics2021
  • 1 - 50 of 127

Recommended Authors

Manisha Ummadi
University of California, San Francisco
Career Start Year 2020
Number of shared co-authors 1
Laura Martin-Sancho
The Scripps Research Institute
Career Start Year 2018
Number of shared co-authors 1
Aminu S Jahun
University of Cambridge, Addenbrooke's Hospital Level 5
Career Start Year 2017
Number of shared co-authors 0
James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 7
Benjamin E Nilsson-Payant
Hanover Medical School
Career Start Year 2017
Number of shared co-authors 4
Tianyang Mao
Yale University School of Medicine
Career Start Year 2017
Number of shared co-authors 0
Mir M Khalid
Gladstone Institutes
Career Start Year 2016
Number of shared co-authors 3
Alexander S Jureka
University of Alabama at Birmingham
Career Start Year 2015
Number of shared co-authors 1
Veronica V Rezelj
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year 2015
Number of shared co-authors 1
Raveen Rathnasinghe
Icahn School of Medicine at Mount Sinai New York
Career Start Year 2015
Number of shared co-authors 2
Stuart Weston
University of Maryland School of Medicine
Career Start Year 2014
Number of shared co-authors 7
Ann-Kathrin Reuschl
University College London
Career Start Year 2013
Number of shared co-authors 0
Chengjin Ye
Texas Biomedical Research Institute
Career Start Year 2013
Number of shared co-authors 0
Shashank Tripathi
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 4
Craig B Wilen
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 6
Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 1
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Career Start Year 2008
Number of shared co-authors 2
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 3
Lisa Miorin
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 4
Michael Schotsaert
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 4
Mohsan Saeed
Boston University Chobanian and Avedisian School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Emmie de Wit
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 10
Balaji Manicassamy
University of Iowa
Career Start Year 2002
Number of shared co-authors 7
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 9
Benjamin R tenOever
NYU Grossman School of Medicine
Career Start Year 2001
Number of shared co-authors 10
James D Chappell
Vanderbilt University Medical Center
Career Start Year 1995
Number of shared co-authors 13
Ignacio Mena
Icahn School of Medicine at Mount Sinai
Career Start Year 1994
Number of shared co-authors 3
Lucy Thorne
University College London
Career Start Year 1992
Number of shared co-authors 0
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Career Start Year 1989
Number of shared co-authors 41
Bart L Haagmans
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 22

Collaborators

Pei-Yong Shi
University of Texas Medical Branch
Co-authored papers 44
Ralph S Baric
University of North Carolina
Co-authored papers 40
Xuping Xie
University of Texas Medical Branch
Co-authored papers 37
Jessica A Plante
Co-authored papers 33
Kenneth S Plante
University of Texas Medical Branch
Co-authored papers 30
Lisa E Gralinski
University of North Carolina at Chapel Hill
Co-authored papers 30
Boyd L Yount
University of North Carolina at Chapel Hill
Co-authored papers 17
Hongjie Xia
University of Texas Medical Branch
Co-authored papers 17
Rachel L Graham
University of North Carolina
Co-authored papers 16
Zhiqiang An
Zhengzhou University
Co-authored papers 15
Sudhakar Agnihothram
National Center for Toxicological Research
Co-authored papers 13
Mehul S Suthar
Co-authored papers 12
Martin T Ferris
University of North Carolina.
Co-authored papers 11
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Co-authored papers 11
Mark T Heise
University of North Carolina at Chapel Hill.
Co-authored papers 9
Katrina M Waters
Pacific Northwest National Laboratory
Co-authored papers 9
Amy C Sims
The University of North Carolina at Chapel Hill
Co-authored papers 9
Fernando Pardo-Manuel de Villena
University of North Carolina
Co-authored papers 8
Sarah R Leist
University of North Carolina at Chapel Hill
Co-authored papers 8
Michael G Katze
University of Washington
Co-authored papers 8
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 8
Scott H Randell
Co-authored papers 7
Steven G Widen
University of Texas Medical Branch
Co-authored papers 7
Alexander N Freiberg
University of Texas Medical Branch
Co-authored papers 7
Darla R Miller
The University of North Carolina at Chapel Hill
Co-authored papers 6
Sophia Jeng
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 6
Eric F Donaldson
Co-authored papers 6
Hugh D Mitchell
Pacific Northwest National Laboratory (PNNL)
Co-authored papers 6
Bobbie-Jo M Webb-Robertson
Pacific Northwest National Laboratory
Co-authored papers 5
Richard D Smith
Pacific Northwest National Laboratory
Co-authored papers 5
Release 1.2